Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs)
NCT01341912
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Hemophilia A
Interventions
BIOLOGICAL:
Human-cl rhFVIII
Sponsor
Octapharma